Results 191 to 200 of about 881,500 (386)

Non‐RASopathy Genetic Syndromes Identified as the Molecular Cause of Disease in Patients Previously Diagnosed With Noonan Syndrome

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Noonan Syndrome (NS) is a clinically and genetically heterogeneous condition characterized by typical facial dysmorphisms, short stature, congenital heart defects, and developmental delays. While variants in genes such as PTPN11, SOS1, and RAF1 account for most genetically confirmed cases, diagnosis is challenging due to phenotypic overlap ...
Gabriela Jeesoo Kim   +9 more
wiley   +1 more source

Effectiveness of cardiac resynchronization therapy in heart failure patients with valvular heart disease: comparison with patients affected by ischaemic heart disease or dilated cardiomyopathy. The InSync/InSync ICD Italian Registry [PDF]

open access: hybrid, 2009
Giuseppe Boriani   +10 more
openalex   +1 more source

Guidelines on the management of valvular heart disease (version 2012).

open access: yesEuropean Heart Journal, 2012
A. Vahanian   +23 more
semanticscholar   +1 more source

Targeted Medical Therapies for Vascular Anomalies: A Clinical Review

open access: yesAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.
ABSTRACT Vascular anomalies represent a broad spectrum of disorders characterized by aberrant blood or lymphatic vessel development, which can lead to complex clinical phenotypes. Historically, vascular anomalies were classified solely on the basis of their clinical and histopathologic features.
Whitney Eng
wiley   +1 more source

Radiofrequency pulmonary veins isolation of atrial fibrillation in patients undergoing mitral valve replacement

open access: yesOpen Medicine, 2006
Grabowski Maciej   +4 more
doaj   +1 more source

Alternative access for transapical transcatheter mitral valve implantationCentral Message

open access: yesJTCVS Techniques, 2023
Heinz Deschka, MD   +3 more
doaj   +1 more source

Pimobendan alleviates myocyte apoptosis and fibrosis associated with mitral regurgitation by targeting endoplasmic reticulum stress

open access: yesAnimal Models and Experimental Medicine, EarlyView.
Mitral regurgitation (MR) causes volume overload and disrupts Ca2+ homeostasis. The volume overload leads to cardiac hypertrophy and fibrosis inferred from histopathological studies. Cardiac hypertrophy was identified by increased myocyte cross‐sectional area, left atrial‐to‐aortic root ratio, and left ventricular internal diameter at end‐diastole ...
Pakit Boonpala   +10 more
wiley   +1 more source

Genetics of Valvular Heart Disease

open access: green, 2014
Stephanie LaHaye, Joy Lincoln, Vidu Garg
openalex   +1 more source

Comparison of postoperative complications following cardiac surgery with or without added surgical ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation

open access: diamond, 2022
Marta Czapka   +13 more
openalex   +2 more sources

A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease.

open access: yesEuropean Heart Journal, 2003
B. Iung   +11 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy